A Multicenter Study of Artificial Intelligence-assisted Contrast-enhanced Ultrasound Diagnosis of Thyroid Nodules
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Trial Details
| Condition | Thyroid Nodule |
| Intervention | Artificial Intelligence |
| Phase | N/A |
| Status | Completed |
| Participants | 1,955 |
| Est. Completion | 2 Mar 2026 |
| Last Updated | 25 Mar 2026 |
Primary Outcome
Diagnostic performance; The necessity of biopsy
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Patients with thyroid nodules with a solid component ≥5 mm confirmed by conventional ultrasound; * Patients who underwent conventional ultrasound, contrast-enhanced ultrasound, and fine-needle aspiration biopsy; * Patients with a final benign or malignant pathological results. Exclusion Criteria: * Patients with cytopathology of Bethesda I, III, or IV and without final benign or malignant pathology; * Patients with a history of thyroid ablation or surgery; * Patients with low-quality ultrasound images.
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service